Ranked #3,382 of 8,699 institutional investors
Eagle Health Investments LP
Greenwich, CT
$561M
US stock portfolio at live prices · today −$4.1M (−0.72%)
Live prices, last trade 12:37 PM ET
- Value at quarter end (Q3 2026)
- $582M
- Change from Q2 2026
- −$21.6M (−3.57%)
- Positions
- 18 · 3 new, 7 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: put options on $26.8M. $116M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesARGX 12.8%INSM 9.29%UTHR 7.89%ISRG 7.83%GH 7.81%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| ARGX argenx SE | 76,593 | $72.0M | 12.8% | Added +0% |
| INSM Insmed Incorporated | 358,702 | $52.1M | 9.29% | Reduced −7% |
| UTHR United Therapeutics Corporation | 79,678 | $44.3M | 7.89% | New |
| ISRG Intuitive Surgical, Inc. | 108,546 | $43.9M | 7.83% | Added +2,373% |
| GH Guardant Health, Inc. | 300,685 | $43.8M | 7.81% | Unchanged |
| PTGX Protagonist Therapeutics, Inc. | 248,322 | $30.4M | 5.43% | Unchanged |
| SRRK Scholar Rock Holding Corporation | 561,527 | $28.3M | 5.04% | Added +1% |
| FTRE Fortrea Holdings Inc. | 1,181,274 | $22.5M | 4.01% | Unchanged |
| BSX Boston Scientific Corporation | 459,114 | $19.6M | 3.49% | Added +24% |
| RVMD Revolution Medicines, Inc. | 120,346 | $19.5M | 3.47% | Unchanged |
| CMPS COMPASS Pathways plc | 2,060,427 | $16.7M | 2.98% | Unchanged |
| KYMR Kymera Therapeutics, Inc. | 119,268 | $13.8M | 2.46% | Reduced −28% |
| REPL Replimune Group, Inc. | 724,787 | $13.8M | 2.46% | New |
| DNTH Dianthus Therapeutics, Inc. | 131,344 | $11.1M | 1.98% | Unchanged |
| AXSM Axsome Therapeutics, Inc. | 65,051 | $8.5M | 1.52% | Unchanged |
| AVTX Avalo Therapeutics, Inc. | 235,093 | $1.6M | 0.28% | Unchanged |
| SMMT Summit Therapeutics Inc. | 154,493 | $1.5M | 0.28% | New |
| IMCR Immunocore Holdings plc | 46,300 | $1.2M | 0.22% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| BMRN BioMarin Pharmaceutical Inc. | 624,676 | $38.1M |
| ILMN Illumina, Inc. | 187,413 | $36.4M |
| RARE Ultragenyx Pharmaceutical Inc. | 884,121 | $14.6M |
| TEM Tempus AI, Inc. | 256,269 | $14.3M |
| IONS Ionis Pharmaceuticals, Inc. | 194,577 | $5.4M |
| NTRA Natera, Inc. | 15,847 | $4.4M |
| LLY Eli Lilly and Company | 1,994 | $2.7M |